Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 9 | 2025 | 969 | 1.750 |
Why?
|
| Rabies virus | 3 | 2022 | 9 | 1.050 |
Why?
|
| Huntington Disease | 4 | 2024 | 161 | 1.030 |
Why?
|
| Rabies | 2 | 2021 | 8 | 0.860 |
Why?
|
| Nucleic Acids | 1 | 2024 | 60 | 0.800 |
Why?
|
| Oligonucleotides | 3 | 2023 | 228 | 0.710 |
Why?
|
| Phosphatidylcholines | 1 | 2021 | 39 | 0.710 |
Why?
|
| Molecular Imaging | 1 | 2021 | 53 | 0.680 |
Why?
|
| Mice | 24 | 2026 | 11209 | 0.630 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 312 | 0.630 |
Why?
|
| Ascorbic Acid | 3 | 2022 | 54 | 0.510 |
Why?
|
| Animals | 26 | 2026 | 21533 | 0.480 |
Why?
|
| Nitrogen Oxides | 1 | 2015 | 11 | 0.470 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 87 | 0.450 |
Why?
|
| Biomarkers | 4 | 2026 | 1473 | 0.390 |
Why?
|
| Contrast Media | 1 | 2015 | 433 | 0.390 |
Why?
|
| Oxidation-Reduction | 4 | 2025 | 331 | 0.380 |
Why?
|
| Insulin-Secreting Cells | 2 | 2026 | 193 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 10 | 2026 | 3468 | 0.350 |
Why?
|
| RNA, Messenger | 3 | 2025 | 1587 | 0.310 |
Why?
|
| Huntingtin Protein | 3 | 2024 | 149 | 0.300 |
Why?
|
| Lysine | 2 | 2019 | 93 | 0.300 |
Why?
|
| Genetic Vectors | 2 | 2026 | 918 | 0.290 |
Why?
|
| Dependovirus | 2 | 2026 | 746 | 0.290 |
Why?
|
| Alleles | 4 | 2022 | 457 | 0.270 |
Why?
|
| Capsid | 2 | 2026 | 102 | 0.260 |
Why?
|
| RNA Interference | 3 | 2025 | 642 | 0.260 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2025 | 144 | 0.250 |
Why?
|
| Brain | 1 | 2015 | 1606 | 0.250 |
Why?
|
| Dasatinib | 1 | 2026 | 6 | 0.250 |
Why?
|
| Abatacept | 1 | 2026 | 67 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2248 | 0.240 |
Why?
|
| Purines | 1 | 2026 | 43 | 0.240 |
Why?
|
| Factor VIII | 2 | 2023 | 32 | 0.240 |
Why?
|
| Gene Transfer Techniques | 2 | 2026 | 327 | 0.240 |
Why?
|
| Myostatin | 1 | 2025 | 19 | 0.230 |
Why?
|
| Volatile Organic Compounds | 1 | 2025 | 22 | 0.230 |
Why?
|
| Acetaminophen | 2 | 2025 | 57 | 0.230 |
Why?
|
| Podocytes | 1 | 2024 | 13 | 0.220 |
Why?
|
| Gene Silencing | 5 | 2025 | 421 | 0.220 |
Why?
|
| Iron | 1 | 2025 | 155 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2026 | 681 | 0.220 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2024 | 8 | 0.210 |
Why?
|
| Integrin alpha5beta1 | 2 | 2023 | 6 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2026 | 209 | 0.210 |
Why?
|
| Immunosuppressive Agents | 1 | 2026 | 384 | 0.210 |
Why?
|
| Liver | 3 | 2025 | 878 | 0.200 |
Why?
|
| Myocardium | 1 | 2025 | 298 | 0.200 |
Why?
|
| Superoxide Dismutase | 2 | 2025 | 226 | 0.200 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 32 | 0.190 |
Why?
|
| Transduction, Genetic | 1 | 2024 | 245 | 0.190 |
Why?
|
| Hemophilia A | 1 | 2023 | 57 | 0.190 |
Why?
|
| Lipids | 1 | 2025 | 328 | 0.190 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 79 | 0.190 |
Why?
|
| Peptide Initiation Factors | 2 | 2019 | 37 | 0.190 |
Why?
|
| PPAR alpha | 1 | 2022 | 34 | 0.190 |
Why?
|
| Humans | 19 | 2026 | 65554 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2024 | 160 | 0.190 |
Why?
|
| Interleukin-15 | 1 | 2022 | 25 | 0.190 |
Why?
|
| Viral Matrix Proteins | 1 | 2022 | 50 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2024 | 200 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2021 | 15 | 0.180 |
Why?
|
| Organophosphonates | 1 | 2021 | 22 | 0.180 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2021 | 29 | 0.180 |
Why?
|
| Osteoarthritis | 1 | 2023 | 146 | 0.180 |
Why?
|
| Glutathione | 1 | 2021 | 58 | 0.180 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 56 | 0.180 |
Why?
|
| Apolipoprotein A-I | 1 | 2021 | 23 | 0.180 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 91 | 0.170 |
Why?
|
| Phospholipids | 1 | 2021 | 82 | 0.170 |
Why?
|
| Aldehyde Reductase | 1 | 2021 | 4 | 0.170 |
Why?
|
| Corticosterone | 1 | 2021 | 24 | 0.170 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 21 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2026 | 632 | 0.170 |
Why?
|
| Cell Nucleus | 1 | 2024 | 639 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 766 | 0.160 |
Why?
|
| Pregnancy-Specific beta 1-Glycoproteins | 1 | 2019 | 1 | 0.160 |
Why?
|
| Polyamines | 1 | 2019 | 13 | 0.160 |
Why?
|
| Trophoblasts | 1 | 2019 | 7 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2025 | 511 | 0.160 |
Why?
|
| Dog Diseases | 1 | 2020 | 64 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2026 | 711 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 325 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2019 | 3 | 0.150 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 458 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2019 | 54 | 0.150 |
Why?
|
| Adenosine Deaminase | 1 | 2018 | 22 | 0.140 |
Why?
|
| RNA Editing | 1 | 2018 | 24 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 49 | 0.140 |
Why?
|
| DNA | 1 | 2023 | 855 | 0.140 |
Why?
|
| RNA, Double-Stranded | 1 | 2018 | 111 | 0.140 |
Why?
|
| Male | 10 | 2026 | 31083 | 0.140 |
Why?
|
| Mutation | 3 | 2024 | 2688 | 0.130 |
Why?
|
| Glucose | 1 | 2019 | 478 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 16 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2026 | 67 | 0.120 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 49 | 0.120 |
Why?
|
| Adiponectin | 1 | 2015 | 38 | 0.120 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 174 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 1 | 2015 | 36 | 0.110 |
Why?
|
| Cadherins | 1 | 2015 | 90 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2015 | 295 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2015 | 194 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 186 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 147 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 447 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2022 | 2149 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2294 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 487 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 511 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1172 | 0.090 |
Why?
|
| Diet, High-Fat | 2 | 2026 | 182 | 0.090 |
Why?
|
| Female | 8 | 2026 | 34131 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 706 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1701 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1217 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2022 | 270 | 0.080 |
Why?
|
| Genetic Therapy | 2 | 2026 | 836 | 0.070 |
Why?
|
| Lung | 2 | 2023 | 972 | 0.060 |
Why?
|
| Xanthine | 1 | 2026 | 2 | 0.060 |
Why?
|
| Factor IX | 1 | 2026 | 8 | 0.060 |
Why?
|
| Breath Tests | 1 | 2025 | 14 | 0.060 |
Why?
|
| Extracellular Vesicles | 1 | 2026 | 48 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| Cathepsins | 1 | 2005 | 34 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 38 | 0.060 |
Why?
|
| Transgenes | 1 | 2026 | 199 | 0.060 |
Why?
|
| Kidney Tubules | 1 | 2024 | 22 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 77 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2024 | 26 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 97 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 1308 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2026 | 528 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2025 | 261 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 180 | 0.050 |
Why?
|
| Protein Binding | 2 | 2019 | 1651 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2025 | 110 | 0.050 |
Why?
|
| trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 1 | 2024 | 1 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2026 | 285 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2005 | 181 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2026 | 218 | 0.050 |
Why?
|
| Phenotype | 2 | 2020 | 1241 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2026 | 323 | 0.050 |
Why?
|
| tau Proteins | 1 | 2025 | 209 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 8 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 114 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2025 | 213 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2023 | 45 | 0.050 |
Why?
|
| Heart | 1 | 2025 | 295 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 274 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 109 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2005 | 242 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 2432 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 151 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 112 | 0.050 |
Why?
|
| Endosomes | 1 | 2023 | 180 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 242 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 94 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2022 | 76 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 133 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 81 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2023 | 181 | 0.050 |
Why?
|
| Sirolimus | 1 | 2022 | 93 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 73 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2023 | 164 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2022 | 153 | 0.040 |
Why?
|
| Thermogenesis | 1 | 2022 | 127 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2022 | 117 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 149 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 124 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 316 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2021 | 33 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 272 | 0.040 |
Why?
|
| Tokyo | 1 | 2020 | 1 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 221 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 350 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 245 | 0.040 |
Why?
|
| Ornithine Decarboxylase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 330 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 432 | 0.040 |
Why?
|
| Immobilized Proteins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 17 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2019 | 25 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 118 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2020 | 142 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 103 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 432 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 216 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 68 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 343 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 395 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 20 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 113 | 0.040 |
Why?
|
| Deamination | 1 | 2018 | 11 | 0.040 |
Why?
|
| Inosine | 1 | 2018 | 5 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 70 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 206 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2018 | 98 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 134 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 146 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 199 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 316 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 877 | 0.040 |
Why?
|
| Adenosine | 1 | 2018 | 78 | 0.030 |
Why?
|
| Seizures | 1 | 2019 | 144 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 310 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2018 | 344 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 478 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 119 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 376 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2019 | 510 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 770 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 1618 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1048 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2068 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 801 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 369 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 679 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 2077 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2015 | 413 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1793 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 18277 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2510 | 0.020 |
Why?
|
| Child | 1 | 2019 | 4681 | 0.020 |
Why?
|
| Adult | 1 | 2026 | 17417 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4831 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2005 | 9 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 13 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2005 | 22 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2005 | 24 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2005 | 30 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2005 | 116 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 142 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 214 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 245 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14958 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 645 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 1394 | 0.010 |
Why?
|